INNOVADERM CRO IS NOW INDERO.

The Future of CROs & Rheumatology

In this World Pharma Today interview, Indero’s Chief Business Officer, Jason Shuris, reflects on how Contract Research Organizations (CROs) are evolving amid rapid changes in the life‑science industry. Shuris also discusses how scientific leadership, consistency of delivery, and a clear therapeutic focus position Indero as a differentiated partner for sponsors. By applying lessons learned from […]

Exploring the Intersections: Dermatology and Rheumatology Insights

Indero is proud to spotlight an insightful discussion featuring Dr. Juan Ovalles, Senior Director, Rheumatology, and Dr. Jasmina Jankicevic, Chief Medical and Scientific Officer. In this webinar, the two leaders unpack the growing convergence between dermatology and rheumatology, exploring how shared biological pathways can drive smarter, more efficient clinical development strategies. As chronic inflammatory diseases […]

6 Effective Strategies to Boost Patient Recruitment in Dermatology and Rheumatology Trials

In the ever-evolving landscape of clinical trials, patient recruitment strategies stand as a critical component. The ability to effectively and efficiently recruit patients can significantly impact the success of a trial. This article explores various strategies and tools to enhance dermatology and rheumatology patient recruitment.   1. Corrective Data Mining Corrective database mining significantly contributes to shortening timelines from […]

Backup Plans in Clinical Trials: A Focus on Rheumatology

Rheumatology clinical trials, by their very nature, are unpredictable. Unforeseen complications can arise, threatening the continuity of the trial. This unpredictability underscores the necessity of backup plans. These plans can mitigate risks and ensure the trial’s continuity. The investment level for a proper backup plan is crucial as the potential loss from missed timelines, missed […]

Enhancing Rheumatoid Arthritis Patient Retention

Maintaining patient participation is a critical factor that can determine the success or failure of a study, particularly in the context of rheumatoid arthritis (RA) clinical trials. Excellent patient retention is a hallmark of quality sites that prioritize patient care and cultivate enduring relationships, leading to enhanced patient loyalty. Effective strategies, such as periodic surveys […]

Rheumatoid Arthritis: The Imperative of Patient Recruitment and Research Opportunities

The Rising Tide of Rheumatoid Arthritis and the Unmet Need Rheumatoid Arthritis (RA) is a severe autoimmune disease with profound physical, emotional, and socioeconomic impacts. Despite the introduction of targeted biological and pharmacological treatments, a significant number of RA patients still suffer from unbearable side effects. The rising prevalence of RA underscores the urgent need […]

Jeff Smith

Chef de la direction

Jeff Smith, Chef de la direction d’Indero Recherches, apporte prĂšs de 30 ans d’expĂ©rience dans l’industrie pharmaceutique et CRO, s’Ă©tant distinguĂ© par son leadership exceptionnel, sa vision stratĂ©gique et son innovation. L’expertise de Jeff couvre des opĂ©rations mondiales, la gestion de la croissance, ainsi que la promotion d’une culture d’entreprise collaborative. Ses atouts en matiĂšre de crĂ©ation de valeur, de gestion des partenaires et d’opĂ©rations CRO ont toujours contribuĂ© au succĂšs dans ses fonctions prĂ©cĂ©dentes. Sous la direction de Jeff, Indero continue d’étendre ses capacitĂ©s, faisant progresser les connaissances mĂ©dicales et les nouvelles thĂ©rapies en dermatologie et en rhumatologie.